Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Naoe

Showing results (1-10 of 321) with videos related to

Pageof 33
Sort By:
International Journal of Hematology|August 22, 2012
Guest editorial: introducing progress in hematology in this issueTomoki Naoe
Oncology|November 10, 2015
Looking Back at the 30th Nagoya International Cancer Treatment SymposiumTomoki Naoe
Nagoya Journal of Medical Science|June 26, 2020
＜Editors' Choice＞ How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitementTomoki Naoe
Current Pharmaceutical Biotechnology|November 2, 2006
Developing target therapy against oncogenic tyrosine kinase in myeloid maliganaciesTomoki Naoe
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 5, 2012
[109th Scientific Meeting of the Japanese Society of Internal Medicine: invited lecture: 5. Molecular target therapy for leukemia]Tomoki Naoe
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 28, 2006
[Recent progress in therapy for hematological malignancies]Tomoki Naoe, Tomohiro Kinoshita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[Circumventing resistance to imatinib therapy in chronic myeloid leukemia]Yosuke Minami, Tomoki Naoe
International Journal of Hematology|January 30, 2013
Gene mutations of acute myeloid leukemia in the genome eraTomoki Naoe, Hitoshi Kiyoi
Leukemia & Lymphoma|October 29, 2002
FLT3 in human hematologic malignanciesHitoshi Kiyoi, Tomoki Naoe
Leukemia & Lymphoma|October 27, 2006
Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: major challenges in current practiceMasamitsu Yanada, Tomoki Naoe
Pageof 33

Showing results (1-10 of 321) with videos related to

Sort By:
Pageof 33
International Journal of Hematology|August 22, 2012
Guest editorial: introducing progress in hematology in this issueTomoki Naoe
Oncology|November 10, 2015
Looking Back at the 30th Nagoya International Cancer Treatment SymposiumTomoki Naoe
Nagoya Journal of Medical Science|June 26, 2020
＜Editors' Choice＞ How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitementTomoki Naoe
Current Pharmaceutical Biotechnology|November 2, 2006
Developing target therapy against oncogenic tyrosine kinase in myeloid maliganaciesTomoki Naoe
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 5, 2012
[109th Scientific Meeting of the Japanese Society of Internal Medicine: invited lecture: 5. Molecular target therapy for leukemia]Tomoki Naoe
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 28, 2006
[Recent progress in therapy for hematological malignancies]Tomoki Naoe, Tomohiro Kinoshita
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[Circumventing resistance to imatinib therapy in chronic myeloid leukemia]Yosuke Minami, Tomoki Naoe
International Journal of Hematology|January 30, 2013
Gene mutations of acute myeloid leukemia in the genome eraTomoki Naoe, Hitoshi Kiyoi
Leukemia & Lymphoma|October 29, 2002
FLT3 in human hematologic malignanciesHitoshi Kiyoi, Tomoki Naoe
Leukemia & Lymphoma|October 27, 2006
Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: major challenges in current practiceMasamitsu Yanada, Tomoki Naoe
Pageof 33